136 related articles for article (PubMed ID: 33909909)
1. Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5.
Sun Y; Gong C; Ni Z; Hu D; Ng W; Zhu X; Wang L; Si G; Yan X; Zhao C; Yao C; Zhu S
J Leukoc Biol; 2021 Aug; 110(2):315-325. PubMed ID: 33909909
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
4. EGFR inhibitors enhanced the susceptibility to NK cell-mediated lysis of lung cancer cells.
Kim H; Kim SH; Kim MJ; Kim SJ; Park SJ; Chung JS; Bae JH; Kang CD
J Immunother; 2011 May; 34(4):372-81. PubMed ID: 21499124
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction.
Bae JH; Kim SJ; Kim MJ; Oh SO; Chung JS; Kim SH; Kang CD
Cancer Sci; 2012 Jan; 103(1):7-16. PubMed ID: 21951556
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells.
Zhang K; Wang J; Jiang H; Xu X; Wang S; Zhang C; Li Z; Gong X; Lu W
Am J Physiol Cell Physiol; 2014 Jan; 306(1):C59-65. PubMed ID: 24153432
[TBL] [Abstract][Full Text] [Related]
8. Grain-sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non-small cell lung cancer.
Hu D; Shen W; Gong C; Fang C; Yao C; Zhu X; Wang L; Zhao C; Zhu S
J Cell Mol Med; 2021 Mar; 25(6):2900-2908. PubMed ID: 33506637
[TBL] [Abstract][Full Text] [Related]
9. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract][Full Text] [Related]
10. COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells.
Kim SJ; Ha GH; Bae JH; Kim GR; Son CH; Park YS; Yang K; Oh SO; Kim SH; Kang CD
Exp Cell Res; 2015 Jan; 330(2):451-459. PubMed ID: 25218028
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity.
Siew YY; Neo SY; Yew HC; Lim SW; Ng YC; Lew SM; Seetoh WG; Seow SV; Koh HL
Int Immunol; 2015 Dec; 27(12):621-32. PubMed ID: 26138671
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate.
Gong C; Yao C; Xu Z; Ni Z; Zhu X; Wang L; Yan X; Zhou W; Zhu S
Mol Immunol; 2017 Mar; 83():23-32. PubMed ID: 28092804
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells.
Lin JY; Ke YM; Lai JS; Ho TF
Phytomedicine; 2015 Sep; 22(10):929-38. PubMed ID: 26321742
[TBL] [Abstract][Full Text] [Related]
14. AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity.
Terry S; Abdou A; Engelsen AST; Buart S; Dessen P; Corgnac S; Collares D; Meurice G; Gausdal G; Baud V; Saintigny P; Lorens JB; Thiery JP; Mami-Chouaib F; Chouaib S
Cancer Immunol Res; 2019 Nov; 7(11):1789-1802. PubMed ID: 31488404
[TBL] [Abstract][Full Text] [Related]
15. Study on the Antitumor Mechanism of Tanshinone IIA In Vivo and In Vitro through the Regulation of PERK-ATF4-HSPA5 Pathway-Mediated Ferroptosis.
Guo C; Zhao W; Wang W; Yao Z; Chen W; Feng X
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611836
[TBL] [Abstract][Full Text] [Related]
16. Role of Sevoflurane on Natural Killer Group 2, Member D-Mediated Immune Response in Non-Small-Cell Lung Cancer: An In Vitro Study.
Jeon S; Kim HK; Kwon JY; Baek SH; Ri HS; Choi HJ; Cho HR; Lee YS; Kim JY; Kim J; Bae J; Lee HJ
Med Sci Monit; 2020 Nov; 26():e926395. PubMed ID: 33139690
[TBL] [Abstract][Full Text] [Related]
17. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
18. 5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.
Zhao L; Wang WJ; Zhang JN; Zhang XY
Asian Pac J Cancer Prev; 2014; 15(9):4039-44. PubMed ID: 24935593
[TBL] [Abstract][Full Text] [Related]
19. CAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction is a major component of SHetA2-induced apoptosis in lung cancer cells.
Lin YD; Chen S; Yue P; Zou W; Benbrook DM; Liu S; Le TC; Berlin KD; Khuri FR; Sun SY
Cancer Res; 2008 Jul; 68(13):5335-44. PubMed ID: 18593935
[TBL] [Abstract][Full Text] [Related]
20. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
